GO:0046223 aflatoxin catabolic process: Detoxification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046223 aflatoxin catabolic process describes the biochemical breakdown of aflatoxins, fungal metabolites that contaminate moldy grains and induce liver cancer.
• Aflatoxin B1 is converted by cytochrome P450 enzymes into the reactive carcinogen aflatoxin B1-8,9-epoxide, which forms DNA adducts and induces a G to T transversion at codon 249 of p53.
• Catabolic processes include both microbial degradation and host metabolic detoxification pathways, such as epoxide hydrolysis, glutathione conjugation, and reduction.
• Key genes involved include cytochrome P450 family members (e.g., CYP1A2, CYP3A4), epoxide hydrolase (EPHX1), and glutathione S-transferases (e.g., GSTM1, GSTT1).
• Understanding aflatoxin catabolism is critical for developing interventions against aflatoxin-induced hepatocellular carcinoma and for engineering detoxifying enzymes.
• Research methods include CRISPR knockout of metabolic genes, LC-MS/MS for metabolite profiling, and reporter assays for DNA damage.
Description
Aflatoxins are toxic and carcinogenic secondary metabolites produced by Aspergillus species, commonly found as contaminants in moldy grains, nuts, and other food commodities. The biological process of aflatoxin catabolic process (GO:0046223) encompasses the chemical reactions and pathways that result in the breakdown of these compounds, thereby reducing their toxicity and carcinogenicity. This process is of paramount importance because aflatoxin B1, the most potent member, is a known human hepatocarcinogen that induces a characteristic G to T transversion at codon 249 of the TP53 tumor suppressor gene, leading to its inactivation. The conversion of aflatoxin to a chemical carcinogen is mediated by cytochrome P450 enzymes, and the balance between activation and detoxification pathways determines individual susceptibility to liver cancer. Research into aflatoxin catabolism spans microbiology, toxicology, and cancer biology, aiming to elucidate enzymatic mechanisms and develop strategies for detoxification. The QuickGO definition highlights the breakdown of aflatoxin, a fungal metabolite that induces liver cancer, and notes its conversion to a carcinogen by P450. This article provides a comprehensive overview of the genes, functions, and research methods associated with GO:0046223, based on authoritative literature.
aflatoxin catabolic process At A Glance
| GO ID | GO:0046223 |
|---|---|
| GO term | aflatoxin catabolic process |
| Ontology | biological_process |
| Synonym | aflatoxin breakdown, aflatoxin catabolism, aflatoxin degradation |
| Major function | Breakdown of aflatoxin, a fungal metabolite and liver carcinogen, through enzymatic and metabolic pathways |
| Related process | Aflatoxin biosynthesis (GO:0046222) and aflatoxin metabolic process (GO:0046222) |
| Key enzymes | Cytochrome P450 (activation), epoxide hydrolase, glutathione S-transferases (detoxification) |
| Carcinogenic mechanism | Aflatoxin B1-8,9-epoxide forms DNA adducts, inducing G to T transversion at TP53 codon 249 |
| Organisms | Fungi (Aspergillus), bacteria, and mammals including humans |
What Is GO:0046223?
The aflatoxin catabolic process (GO:0046223) is defined as the set of chemical reactions and pathways that result in the breakdown of aflatoxin, a fungal metabolite found as a contaminant in moldy grains that induces liver cancer. Aflatoxin induces a G to T transversion at codon 249 of p53, leading to its inactivation, and is converted to a chemical carcinogen by P450 enzymes. This process includes both enzymatic degradation of aflatoxin molecules and metabolic detoxification pathways that convert aflatoxins into less toxic or excretable forms.
Why Is aflatoxin catabolic process Important in Cell Biology?
The aflatoxin catabolic process is critically important because it represents the primary means by which organisms mitigate the toxicity of aflatoxins, which are widespread food contaminants and potent human carcinogens. Aflatoxin B1 exposure is a major risk factor for hepatocellular carcinoma, particularly in regions with high contamination of staple crops. Understanding the catabolic pathways enables the development of strategies to reduce aflatoxin levels in food and feed, and to identify individuals at risk due to genetic variations in detoxification enzymes. Moreover, microbial degradation of aflatoxins offers a promising approach for bioremediation.
• Aflatoxin B1 is a group 1 human carcinogen and a major cause of hepatocellular carcinoma worldwide.
• The catabolic process determines the balance between detoxification and activation of aflatoxin, influencing cancer risk.
• Genetic polymorphisms in detoxification enzymes (e.g., GSTM1, GSTT1) modulate individual susceptibility to aflatoxin-induced liver cancer.
• Microbial aflatoxin degradation is a potential strategy for food and feed safety.
• Understanding catabolic pathways aids in the development of biomarkers for exposure and risk assessment.
• Aflatoxin catabolism is relevant to agricultural and food industries for reducing economic losses and health hazards.
• Enzymatic detoxification of aflatoxins can be harnessed for bioremediation of contaminated environments.
• Research on aflatoxin catabolism informs public health policies and intervention strategies in high-risk regions.
• The process is a target for genetic engineering to enhance crop resistance to aflatoxin accumulation.
• Studying aflatoxin catabolism provides insights into fundamental enzymatic mechanisms of xenobiotic metabolism.
What Happens During aflatoxin catabolic process?
Activation by Cytochrome P450
In simple terms: The body tries to break down aflatoxin, but sometimes this first step accidentally makes it more dangerous.
Aflatoxin B1 is metabolized by cytochrome P450 enzymes, primarily CYP1A2 and CYP3A4, to form aflatoxin B1-8,9-epoxide, a highly reactive and carcinogenic intermediate. This epoxide can bind to DNA, forming adducts that lead to mutations, particularly a G to T transversion at codon 249 of the TP53 gene. This activation step is a double-edged sword: while it is part of the catabolic process, it also generates the ultimate carcinogen.
Detoxification by Epoxide Hydrolase and Glutathione S-Transferases
In simple terms: The body has enzymes that can neutralize the dangerous epoxide before it damages DNA.
The reactive aflatoxin B1-8,9-epoxide can be detoxified by epoxide hydrolase (EPHX1) to form aflatoxin B1-8,9-dihydrodiol, which is less toxic. Alternatively, glutathione S-transferases (GSTs), such as GSTM1 and GSTT1, catalyze the conjugation of the epoxide with glutathione, facilitating its excretion. These detoxification pathways are crucial for protecting cells from aflatoxin-induced damage, and their efficiency varies among individuals due to genetic polymorphisms.
Microbial Degradation of Aflatoxins
In simple terms: Some bacteria and fungi can break down aflatoxins directly, offering a natural way to clean up contaminated food.
Various microorganisms, including bacteria and fungi, possess enzymes that can degrade aflatoxins. For example, certain Bacillus and Pseudomonas species produce aflatoxin-degrading enzymes, such as laccases and peroxidases, that oxidize or reduce the aflatoxin molecule. Fungal species like Aspergillus niger and Pleurotus ostreatus can also degrade aflatoxins through enzymatic action. These microbial catabolic pathways are of interest for bioremediation and for reducing aflatoxin contamination in food and feed.
Reduction and Hydrolysis Pathways
In simple terms: Aflatoxins can be broken down by adding electrons or water, making them less harmful.
Aflatoxin B1 can be reduced to aflatoxicol by cytosolic reductases, a reversible reaction that may serve as a reservoir for the toxin. Hydrolytic pathways can also open the lactone ring of aflatoxin, leading to less toxic products. These reactions contribute to the overall catabolic process and can influence the persistence of aflatoxin in biological systems.
Regulation of Aflatoxin Catabolism
In simple terms: The speed and efficiency of aflatoxin breakdown are controlled by many factors, including genes and environment.
The expression and activity of enzymes involved in aflatoxin catabolism are regulated at multiple levels. For instance, cytochrome P450 enzymes can be induced by various xenobiotics, while GSTs are regulated by the Nrf2/ARE pathway. Genetic polymorphisms in these enzymes significantly affect individual capacity to detoxify aflatoxins. Additionally, in fungi, aflatoxin biosynthesis (the opposite process) is regulated by a complex network of transcription factors and signaling pathways, which indirectly influences catabolism.
Key Genes Involved in GO:0046223 aflatoxin catabolic process
The following genes and their protein products are key players in the aflatoxin catabolic process, encompassing activation, detoxification, and microbial degradation pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP1A2 | Activates aflatoxin B1 to the carcinogenic epoxide | Polymorphisms affect aflatoxin activation and cancer risk |
| CYP3A4 | Activates aflatoxin B1 to the carcinogenic epoxide | Major P450 involved in aflatoxin metabolism in human liver |
| EPHX1 | Hydrolyzes aflatoxin B1-8,9-epoxide to dihydrodiol | Detoxification enzyme; variants linked to altered cancer susceptibility |
| GSTM1 | Conjugates aflatoxin epoxide with glutathione | Null genotype associated with increased risk of hepatocellular carcinoma |
| GSTT1 | Conjugates aflatoxin epoxide with glutathione | Polymorphisms influence detoxification capacity |
| GSTP1 | Conjugates aflatoxin epoxide with glutathione | May play a role in aflatoxin detoxification in extrahepatic tissues |
| AKR7A2 | Reduces aflatoxin B1 dialdehyde to less toxic alcohols | Protects against aflatoxin-induced cytotoxicity |
| Aflatoxin B1 aldehyde reductase | Reduces aflatoxin B1 dialdehyde | Detoxification of aflatoxin-derived aldehydes |
| AflM | Involved in aflatoxin biosynthesis (opposite process) | Regulation of biosynthesis affects catabolism indirectly |
| AflR | Transcriptional regulator of aflatoxin biosynthesis | Master regulator of aflatoxin gene cluster |
| AflS | Transcriptional regulator of aflatoxin biosynthesis | Regulates genes in the aflatoxin cluster |
| Laccase | Oxidizes aflatoxin B1 in microbial degradation | Potential bioremediation enzyme |
| Manganese peroxidase | Degrades aflatoxin through oxidation | Fungal enzyme for aflatoxin detoxification |
| Aflatoxin oxidase | Catalyzes aflatoxin oxidation | Enzyme from Armillariella tabescens for detoxification |
| F420-dependent reductase | Reduces aflatoxin in mycobacteria | Novel microbial degradation pathway |
| Cytochrome P450 (fungal) | May contribute to aflatoxin turnover | Potential target for controlling aflatoxin accumulation |
| SCS | Succinylates AflM, affecting aflatoxin biosynthesis | Regulation of biosynthesis via post-translational modification |
How Is aflatoxin catabolic process Regulated?
The aflatoxin catabolic process is regulated at multiple levels. In mammals, the expression of cytochrome P450 enzymes (CYP1A2, CYP3A4) and phase II detoxification enzymes (GSTs, EPHX1) is modulated by transcription factors such as AhR and Nrf2. Genetic polymorphisms in these genes significantly influence individual detoxification capacity and cancer risk. In fungi, aflatoxin biosynthesis is tightly regulated by a cluster of genes including aflR and aflS, and recent studies have shown that post-translational modifications, such as succinylation of AflM by SCS, contribute to the regulation of aflatoxin production. Understanding these regulatory mechanisms is essential for developing interventions to enhance detoxification and reduce aflatoxin toxicity.
aflatoxin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP1A2 | Hepatocellular carcinoma (activation of aflatoxin) | CYP1A2 knockout mice or human hepatocytes |
| GSTM1 | Increased risk of hepatocellular carcinoma (detoxification) | GSTM1-null human cell lines or knockout mice |
| EPHX1 | Modulation of aflatoxin-induced DNA damage | EPHX1 knockout or overexpression cell models |
| TP53 | Aflatoxin-induced TP53 mutation (codon 249) | TP53 knock-in cell lines with R249S mutation |
| AflR | Regulation of aflatoxin biosynthesis (fungal) | Aspergillus flavus knockout strains |
Aflatoxin Catabolism and Hepatocellular Carcinoma
Aflatoxin B1 is a potent hepatocarcinogen, and its catabolic process determines the extent of DNA damage and cancer risk. The reactive epoxide formed by CYP enzymes can induce a G to T transversion at codon 249 of TP53, a mutation frequently found in hepatocellular carcinoma from aflatoxin-endemic regions. Efficient detoxification by GSTs and EPHX1 reduces the formation of DNA adducts and lowers cancer risk. Thus, variations in catabolic enzyme activities are critical determinants of susceptibility to aflatoxin-induced liver cancer.
Aflatoxin Catabolism and Other Diseases
Beyond liver cancer, aflatoxin exposure has been linked to growth impairment, immune suppression, and other cancers. The catabolic process influences systemic exposure to aflatoxin and its metabolites, which can affect multiple organs. For example, aflatoxin B1 can be metabolized in extrahepatic tissues, and the balance of activation and detoxification there may contribute to other pathologies. Understanding catabolism in different tissues is important for assessing overall health risks.
Microbial Degradation and Bioremediation
Microbial catabolism of aflatoxins offers a promising strategy for reducing contamination in food and feed, thereby preventing human exposure and disease. Enzymes such as laccases and peroxidases from bacteria and fungi can degrade aflatoxins into less toxic products. Harnessing these microbial pathways through biotechnology could lead to novel detoxification methods for agricultural commodities.
From aflatoxin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X detoxify aflatoxin B1-8,9-epoxide? | CRISPR knockout of gene X in HepG2 cells followed by aflatoxin treatment and DNA adduct measurement |
| What is the effect of a point mutation in TP53 on aflatoxin-induced carcinogenesis? | Knock-in of TP53 R249S mutation in human hepatocytes |
| Can a candidate gene enhance aflatoxin degradation? | Overexpression of the gene in E. coli or yeast and aflatoxin degradation assay |
| What is the role of a specific GST in aflatoxin detoxification? | Knockout of GST in mouse models and assessment of aflatoxin-DNA adducts |
| How does aflatoxin affect global gene expression? | RNA-seq of aflatoxin-treated wild-type and knockout cells |
| Can CRISPR screening identify novel aflatoxin resistance genes? | Genome-wide CRISPR knockout library in aflatoxin-sensitive cells |
How to Study the aflatoxin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Aflatoxin metabolites and detoxification products | Quantifying catabolic pathway flux |
| ELISA for DNA adducts | Aflatoxin-DNA adduct levels | Biomonitoring of exposure and effect |
| CRISPR knockout | Gene function in aflatoxin catabolism | Identifying causal genes |
| RNA-seq | Global gene expression changes | Discovering pathways affected by aflatoxin |
| Western blot | Protein expression of detoxification enzymes | Validating gene expression changes |
| Enzyme activity assays | Catalytic activity of GSTs, EPHX1, etc. | Functional characterization of enzymes |
| Aflatoxin degradation assay | Microbial degradation of aflatoxin | Screening for bioremediation enzymes |
| Reporter assay for TP53 mutation | Frequency of G to T transversion | Assessing mutagenicity of aflatoxin |
Metabolite Profiling by LC-MS/MS
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is used to quantify aflatoxin metabolites, including aflatoxin B1, its epoxide, and detoxification products such as glutathione conjugates. This method allows researchers to track the catabolic process in cells and tissues, providing insights into enzyme activities and pathway flux.
DNA Adduct Measurement
Aflatoxin-DNA adducts, particularly aflatoxin B1-N7-guanine, can be measured using techniques such as immunohistochemistry, ELISA, or mass spectrometry. These adducts are biomarkers of exposure and effect, and their levels reflect the balance between activation and detoxification.
CRISPR-Cas9 Gene Editing
CRISPR-Cas9 is employed to generate knockout or knock-in cell models to study the function of specific genes in aflatoxin catabolism. For example, knocking out CYP1A2 or GSTM1 can reveal their roles in aflatoxin activation and detoxification, respectively. This approach enables causal inference in aflatoxin research.
Reporter Assays for TP53 Mutation
Reporter assays can detect the specific G to T transversion at codon 249 of TP53 induced by aflatoxin. These assays use fluorescent or luminescent reporters to quantify mutation frequency and can be used to screen for compounds that prevent or enhance aflatoxin-induced mutagenesis.
How CRISPR Can Be Used to Study GO:0046223 aflatoxin catabolic process
Knockout
CRISPR knockout of genes involved in aflatoxin catabolism, such as CYP1A2, GSTM1, or EPHX1, allows researchers to determine their specific contributions to detoxification or activation. For example, knocking out GSTM1 in HepG2 cells increases sensitivity to aflatoxin-induced DNA damage, confirming its protective role. Knockout models are essential for establishing causality in aflatoxin research.
Point Mutation
CRISPR point mutation can introduce specific single-nucleotide changes, such as the TP53 R249S mutation, to study their impact on aflatoxin-induced carcinogenesis. This approach mimics the mutation found in human tumors and helps elucidate the molecular mechanisms of aflatoxin-driven cancer. Point mutation models are valuable for testing targeted therapies.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, FLAG) into endogenous loci of aflatoxin-metabolizing enzymes enables real-time tracking of protein expression and localization. For instance, knocking in a fluorescent tag into CYP1A2 allows visualization of its induction and subcellular distribution upon aflatoxin exposure. Knock-in models facilitate detailed mechanistic studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase the expression of detoxification enzymes to study their protective effects against aflatoxin. Overexpression of GSTM1 or EPHX1 in cell lines can reduce aflatoxin-DNA adduct formation, demonstrating their detoxifying capacity. This approach is useful for identifying potential therapeutic targets.
How EDITGENE Supports aflatoxin catabolic process Research
Researchers studying aflatoxin catabolic process-related genes often need to determine whether a candidate gene is causally involved in detoxification or activation, and to dissect the underlying molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for aflatoxin catabolic process research.
Frequently Asked Questions About aflatoxin catabolic process
What is aflatoxin catabolic process?
Aflatoxin catabolic process (GO:0046223) is the set of biochemical reactions that break down aflatoxins, which are toxic fungal metabolites found in moldy grains and linked to liver cancer.
What genes are involved in aflatoxin catabolic process?
Key genes include cytochrome P450 enzymes (CYP1A2, CYP3A4) that activate aflatoxin, and detoxification enzymes such as EPHX1, GSTM1, and GSTT1 that neutralize the reactive intermediates.
How does aflatoxin cause liver cancer?
Aflatoxin B1 is converted by P450 enzymes to a reactive epoxide that forms DNA adducts, leading to a G to T mutation at codon 249 of the TP53 gene, which inactivates the tumor suppressor and contributes to liver cancer.
What is the role of glutathione S-transferases in aflatoxin detoxification?
GSTs catalyze the conjugation of the reactive aflatoxin epoxide with glutathione, making it more water-soluble and easier to excrete, thereby reducing DNA damage.
Can aflatoxin be degraded by microorganisms?
Yes, certain bacteria and fungi produce enzymes such as laccases and peroxidases that can degrade aflatoxins, offering potential for bioremediation.
What are the synonyms for aflatoxin catabolic process?
The synonyms are aflatoxin breakdown, aflatoxin catabolism, and aflatoxin degradation.
How is aflatoxin catabolic process studied?
It is studied using methods such as LC-MS/MS for metabolite profiling, DNA adduct measurement, CRISPR knockout models, and enzyme activity assays.
What is the connection between aflatoxin and TP53 mutations?
Aflatoxin B1 induces a specific G to T transversion at codon 249 of TP53, a mutation frequently found in hepatocellular carcinoma from aflatoxin-endemic regions.
Are there genetic variations that affect aflatoxin detoxification?
Yes, polymorphisms in genes like GSTM1, GSTT1, and EPHX1 can alter detoxification capacity and influence individual susceptibility to aflatoxin-related diseases.
What is the opposite of aflatoxin catabolic process?
The opposite is aflatoxin biosynthesis (GO:0046222), the process by which fungi produce aflatoxins.
Conclusion
The aflatoxin catabolic process (GO:0046223) is a critical biological pathway that determines the fate and toxicity of aflatoxins, widespread food contaminants and potent carcinogens. Understanding the enzymes and regulatory mechanisms involved in this process is essential for developing strategies to prevent aflatoxin-induced liver cancer and to remediate contaminated food and feed. Continued research using advanced CRISPR models and analytical techniques will further elucidate the complexities of aflatoxin catabolism and translate findings into public health benefits.
References
- 1. Cao W et al.. 2022. Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development.. Toxicol Mech Methods 32(6):395-419 PMID: 34930097
- 4. Wu Q et al.. 2009. Biological degradation of aflatoxins.. Drug Metab Rev 41(1):1-7 PMID: 19514968
- 5. Yabe K et al.. 2011. [Aflatoxin biosynthesis].. Shokuhin Eiseigaku Zasshi 52(3):135-47 PMID: 21720118
- 7. Molyneux RJ et al.. 2007. Mycotoxins in edible tree nuts.. Int J Food Microbiol 119(1-2):72-8 PMID: 17719114
- 8. Xie R et al.. 2025. STA regulates succinylated AflM triggered by SCS to contribute to aflatoxin biosynthesis through the Ach1.. Virulence 16(1):2532812 PMID: 40679121
